Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.63 USD | -4.26% | -11.48% | +17.39% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.39% | 484M | |
-0.28% | 90.59B | |
-0.92% | 38.99B | |
-9.57% | 34.09B | |
+64.64% | 26.38B | |
-17.98% | 15.02B | |
-6.74% | 13.17B | |
-9.76% | 11.88B | |
-47.31% | 10.65B | |
+6.97% | 9.25B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Transcript : Avid Bioservices, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-09-2021 02